Benlysta Approved for Systemic Lupus Erythematosus - ONA
Links shared publicly online about this topic.
- 449total visits
Benlysta Approved for Systemic Lupus Erythematosus - ONA
View full resource at oncologynurseadvisor.com
Tags: Lupus, Systemic Lupus Erythematosus, Drug, FDA, NSAIDs, GlaxoSmithKline, Science
Most Recently Shared on March 10, 2011 at 6:03 pm By:
Benlysta Approved for Systemic Lupus Erythematosus http://goo.gl/fb/U2aYI
Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting
news-medical.net — “Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.” View full resource at news-medical.net
Most Recently Shared on November 5, 2011 at 3:21 pm By:
Pregnancy News: Human Genome Sciences to present abstracts regarding BENLYSTA, SLE at ACR/ARHP meeting: Human Ge... http://t.co/Lh4mkMAs
RxEconsult, LLC - Benlysta (belimumab) for systemic lupus erythematosus (SLE)
rxeconsult.com — “RxEconsult, LLC - Benlysta (belimumab) for systemic lupus erythematosus (SLE)” View full resource at rxeconsult.com
Most Recently Shared on October 7, 2011 at 11:44 pm By:
RxEconsult. If you are in need of healthcare services or information, please visit RxEconsult.
Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.
Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Doctor, Pharmacist, PharmD, and Active Health Library
#Benlysta (#belimumab) for systemic #lupus erythematosus (SLE) http://t.co/3TpzMnEj #Medications #healthcare
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 14, 2011 at 4:24 pm By:
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/w7lzkW8
FDA approves Benlysta for SLE, Horizant for RLS - - Drug Topics
drugtopics.modernmedicine.com — “Systemic lupus erythematosus is a serious, potentially fatal autoimmune disease that affects between 300,000 to 1.5 million Americans of all races. Restless legs syndrome is a disruptive neurologic disorder that affects up to 10% of all Americans.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on August 13, 2011 at 4:09 am By:
Drugs and Devices OW OW Health
FDA approves Benlysta for SLE, Horizant for RLS: Systemic lupus erythematosus is a serious, potentially fatal au... http://t.co/2yvpXCZ
EC grants marketing authorization for BENLYSTA to treat SLE
news-medical.net — “GlaxoSmithKline and Human Genome Sciences, Inc. announced today that the European Commission has granted marketing authorization for BENLYSTA 10mg/kg as an add-on therapy in adult patients with active autoantibody-positive systemic lupus erythematosus, with a high degree of disease activity, despite standard therapy.” View full resource at news-medical.net
Most Recently Shared on July 14, 2011 at 11:34 am By:
EC grants marketing authorization for BENLYSTA to treat SLE: GlaxoSmithKline and Human Genome Sciences, Inc. ann... http://bit.ly/pyXn1u
BENLYSTA (Belimumab) drug information from MPR
empr.com — “BENLYSTA (Belimumab) drug information for Systemic lupus erythematosus from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 10, 2011 at 4:51 am By:
MPR News: BENLYSTA: Monograph added. http://bit.ly/ltyOH0
Medical News: The Long, Winding Road to a Lupus Drug - in Rheumatology, Lupus from MedPage TodayMedical News: The Long, Winding Road to a Lupus Drug - in Rheumatology, Lupus from MedPage TodayMedical News: The Long, Winding Road to a Lupus Drug - in Rheum
medpagetoday.com — “In March, the first new drug for systemic lupus erythematosus in more than 50 years was approved by the FDA, and it's been nearly that long since John Lennon's young son, Julian, drew a fantastical p” View full resource at medpagetoday.com
Most Recently Shared on June 1, 2011 at 2:20 pm By:
The long, winding road to a lupus drug: http://bit.ly/iP7Wvy
BENLYSTA - New Product Releases - MPR
empr.com — “Systemic lupus erythematosus, in adults with active, autoantibody-positive SLE on standard therapy.” View full resource at empr.com
Most Recently Shared on April 1, 2011 at 2:10 pm By:
MPR News: BENLYSTA: Belimumab120mg/vial, 400mg/vial; pwd for IV infusion after reconÂstitution and dilution. http://bit.ly/dTrvvi
New Lupus Therapy Approval Coincides With Autoimmune Diseases Awareness Month
medicalnewstoday.com — “The Food and Drug Administration (FDA) approved Benlysta® (belimumab), a new biologic therapy developed to treat patients suffering from active, autoantibody-positive systemic lupus erythemato” View full resource at medicalnewstoday.com
Most Recently Shared on March 12, 2011 at 9:05 am By:
New Lupus Therapy Approval Coincides With Autoimmune Diseases Awareness Month http://mnt.to/3Sdc #vaccines #immunesystem
FDA Approves Benlysta to Treat Lupus
drugs.com — “Benlysta (belimumab) is used to treat systemic lupus erythematosus. Includes Benlysta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 10, 2011 at 11:44 pm By:
FDA Approves Benlysta to Treat Lupus - http://bit.ly/i2dxtA
New Lupus Drug Benlysta Offers Long-Awaited Hope « CBS New York
newyork.cbslocal.com — “The FDA today approved the first new drug to treat lupus in over 50 years, a milestone that medical experts say could prompt development of other drugs that are even more effective in treating the debilitating immune system disorder. News, Sports, Weather, Traffic and the Best of NY” View full resource at newyork.cbslocal.com
Most Recently Shared on March 10, 2011 at 10:17 pm By:
RT @lupusny: RT @EyeOnNY: New Lupus Drug Benlysta Offers Long-Awaited Hope: http://goo.gl/fb/v0ns3
FDA Approves Benlysta to Treat Lupus
drugs.com — “Benlysta (belimumab) is used to treat systemic lupus erythematosus. Includes Benlysta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 10, 2011 at 10:11 pm By:
Drugs and Devices OW OW Health
FDA Approves Benlysta to Treat Lupus: March 9, 2011 -- The U.S. Food and Drug Administration today approve... http://bit.ly/fHqtG8 #drug
First new lupus drug approved by FDA in more than 50 years
orthosupersite.com — “The FDA has approved belimumab to treat patients with active, autoantibody-positive lupus —systemic lupus erythematosus — who are receiving ...” View full resource at orthosupersite.com
Most Recently Shared on March 10, 2011 at 9:33 pm By:
Thomas Loarie, Jr Health Advocate
First new lupus drug approved by FDA in more than 50 years http://t.co/TyAhvBw #lupus #health #pharma #medicine
PharmaLive: Human Genome Sciences and GlaxoSmithKline Announce FDA Approval of Benlysta (Belimumab) for Treatment of Systemic Lupus Erythematosus
pharmalive.com — “PharmaLive: Human Genome Sciences and GlaxoSmithKline Announce FDA Approval of Benlysta (Belimumab) for Treatment of Systemic Lupus Erythematosus” View full resource at pharmalive.com
Most Recently Shared on March 10, 2011 at 7:36 pm By:
PharmaLive Pharma and Health News
Daily Advantage - FDA Approves Lupus Drug - http://tinyurl.com/48s7f3b
Benlysta (belimumab) Side Effects, Warnings and Precautions, Dosing, and mechinisam of action is included on MedicineNet.com
medicinenet.com — “Information on the drug Benlysta (belimumab) prescribed for the treatment off systemic lupus erythematosus. Side effects, warnings and precautions, and drug interactions are included.” View full resource at medicinenet.com
Most Recently Shared on March 10, 2011 at 6:00 pm By:
Benlysta (belimumab) Approved for Lupus Treatment http://bit.ly/eEdlQQ
Advertisement
